Your browser doesn't support javascript.
loading
Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant.
Benotmane, Ilies; Velay, Aurélie; Gautier-Vargas, Gabriela; Olagne, Jérôme; Thaunat, Olivier; Fafi-Kremer, Samira; Caillard, Sophie.
Affiliation
  • Benotmane I; Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.
  • Velay A; Department of Transplantation, Nephrology and Clinical Immunology, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France.
  • Gautier-Vargas G; Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.
  • Olagne J; Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.
  • Thaunat O; Department of Transplantation, Nephrology and Clinical Immunology, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France.
  • Fafi-Kremer S; Department of Virology, Strasbourg University Hospital, Strasbourg, France.
  • Caillard S; Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France. Electronic address: Sophie.caillard@chru-strasbourg.fr.
Kidney Int ; 102(2): 442-444, 2022 08.
Article in En | MEDLINE | ID: mdl-35618094
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Pre-Exposure Prophylaxis Limits: Humans Language: En Journal: Kidney Int Year: 2022 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Pre-Exposure Prophylaxis Limits: Humans Language: En Journal: Kidney Int Year: 2022 Type: Article Affiliation country: France